Pure Global AI
NCT06059079Completed

Using Higher Cut-off Values to Diagnose Acute Myocardial Infarction in Patients With Elevated Hs-cTnT Concentrations

The First Affiliated Hospital with Nanjing Medical UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Acute Myocardial Infarction
Drug/Device/Intervention
No Intervention
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
The First Affiliated Hospital with Nanjing Medical University
Location
Nanjing, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2015
End date
May 31, 2023
Enrollment
80000 participants
Primary outcome

Number of patients diagnosed with acute myocardial infarction

Summary

High-sensitive cardiac troponin T (hs-cTnT) is a cornerstone for diagnosing acute myocardial
 infarction (AMI). However, it is often challenging to diagnose AMI in patients with elevated
 hs-cTnT before a rise or fall of hs-cTnT can be observed. The elevations of hs-cTnT are
 caused not only by AMI, but also by other cardiac or even non-cardiac diseases. Thresholds
 above the 99th percentile have been proposed to improve the specificity and to accelerate the
 rule in of myocardial infarction. This study aimed to find a more accurate cut-off value to
 rule in AMI in patients with elevated hs-cTnT.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedAcute subendocardial myocardial infarctionCertain current complications following acute myocardial infarctionOther current complications following acute myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06059079
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06059079 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital with Nanjing Medical University and is currently Completed. The study focuses on Acute Myocardial Infarction. Target enrollment is 80000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.